Trinity Biotech | TRIB - Ebitda





Ebitda Veränderung Datum
Abbott USD 2.43B 844M 2026-03
Bayer EUR 4.45B 2.49B 2026-03
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
J&J USD 8.27B 1.08B 2026-03
Mesa Laboratories USD 9.58M 1.47M 2024-09
OraSure Technologies USD -17.7M 4.06M 2025-12
Plus Therapeutics USD -4.4M 2.94M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Siemens EUR 3.56B 80M 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Tosoh JPY 39.13B 286M 2024-12
Trinity Biotech USD -9.6M 7.64M 2024-12
Veracyte USD 42.8M 488K 2026-03